title: A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
authors.forename: R
authors.initials: R
authors.lastname: Burgos-Vargas
authors.forename: J
authors.initials: J
authors.lastname: Vázquez-Mellado
authors.forename: C
authors.initials: C
authors.lastname: Pacheco-Tena
authors.forename: A
authors.initials: A
authors.lastname: Hernández-Garduño
authors.forename: M V
authors.initials: MV
authors.lastname: Goycochea-Robles
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D011446:Prospective Studies; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D012460:Sulfasalazine / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D012460:Sulfasalazine